Get the Stockscreener App
24.14
2.16%
0.51
After Hours:
24.14
Zai Lab Limited Adr stock is traded at $24.14, with a volume of 832.36K.
It is up +2.16% in the last 24 hours and up +21.06% over the past month.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
See More
Previous Close:
$23.63
Open:
$24.04
24h Volume:
832.36K
Relative Volume:
1.44
Market Cap:
$2.35B
Revenue:
$266.72M
Net Income/Loss:
$-334.62M
P/E Ratio:
-5.8878
EPS:
-4.1
Net Cash Flow:
$-206.67M
1W Performance:
+16.51%
1M Performance:
+21.06%
6M Performance:
+50.69%
1Y Performance:
-0.70%
1-Day Range:
$23.77
$25.02
1-Week Range:
$20.17
$25.02
52-Week Range:
$13.48
$31.22
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Name
Zai Lab Limited Adr
Sector
Industry
Phone
862161632588
Address
4560 JINKE ROAD, SHANGHAI
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-14-23 | Initiated | Morgan Stanley | Overweight |
| Aug-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-21-22 | Initiated | Macquarie | Outperform |
| Oct-12-21 | Initiated | Bernstein | Mkt Perform |
| Apr-28-20 | Initiated | Goldman | Buy |
| Apr-15-20 | Initiated | Guggenheim | Buy |
| Jul-12-19 | Initiated | BofA/Merrill | Buy |
| Jul-05-19 | Initiated | Macquarie | Outperform |
| Jan-29-19 | Initiated | Credit Suisse | Outperform |
| Nov-21-18 | Initiated | Jefferies | Buy |
| Jun-21-18 | Resumed | Leerink Partners | Outperform |
| Feb-14-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-16-17 | Initiated | JP Morgan | Neutral |
| Oct-16-17 | Initiated | Leerink Partners | Outperform |
View All
Zai Lab Limited Adr Stock (ZLAB) Latest News
Monitoring Maravai LifeSciences Holdings Inc (MRVI) after recent insider movements - Knox Daily
Examining the Potential Price Growth of CRISPR Therapeutics AG (CRSP) - Knox Daily
It would be worthwhile to take a closer look at Zai Lab Limited ADR (ZLAB) - US Post News
Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains? - Yahoo Finance
Zai Lab (NASDAQ:ZLAB) Shares Up 10.1% - Defense World
Zai Lab Limited ADR (ZLAB) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Financial Metrics Exploration: Understanding Zai Lab Limited ADR (ZLAB) Through Ratios - The Dwinnex
Taking a look at what insiders are doing to gauge the Zai Lab Limited ADR (ZLAB)’s direction - Knox Daily
Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $21.57 - Defense World
Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.5% - Defense World
Analysts review Zai Lab Limited ADR’s rating - Knox Daily
Zai Lab (NASDAQ:ZLAB) Has Debt But No Earnings; Should You Worry? - Simply Wall St
DekaBank Deutsche Girozentrale Sells 6,648 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
30,450 Shares in Zai Lab Limited (NASDAQ:ZLAB) Bought by DCF Advisers LLC - Defense World
DCF Advisers LLC Takes Position in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
HR Stock Sees Decline of Approximately -1.31% in Last Five Days - Knox Daily
The Zai Lab Limited ADR (ZLAB) had a good session last reading, didn’t it? - US Post News
Selling Buzz: CubeSmart [CUBE] Chief Human Resources Officer Schulte Jennifer sells 15,942 shares of the company - Knox Daily
Headlands Technologies LLC Cuts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024 - BioSpace
Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024 - Business Wire
What is Zai Lab Limited ADR (ZLAB) Stock Return on Shareholders’ Capital? - SETE News
Taking a Closer Look At Accuray Inc (ARAY) Following Its Recent Trade - Knox Daily
Upward Trajectory: Zai Lab Limited ADR (ZLAB) Posts a Slidee, Closing at 20.51 - The Dwinnex
Ryan Specialty Holdings Inc [RYAN] Investment Appeal on the Rise - Knox Daily
Can you still get a good price for Zai Lab Limited ADR (ZLAB) Shares at this point? - US Post News
Zai Lab Limited (NASDAQ:ZLAB) Shares Acquired by TD Asset Management Inc - Defense World
IMNN (Imunon Inc) may reap gains as insiders became active recently - Knox Daily
Candriam S.C.A. Cuts Stake in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
This trade activity should not be overlooked: Zai Lab Limited ADR (ZLAB) - SETE News
Insider Selling: GAYNOR RICHARD, Zai Lab Limited ADR [ZLAB] Director divested 2,500 shares - Knox Daily
Amphenol Corp. (APH) Analyst Thoughts: How High Can It Go? - Stocks Register
Zai Lab Limited ADR (ZLAB) deserves closer scrutiny - US Post News
Ouster Inc [OUST] Chief Financial Officer makes an insider purchase of 519 shares worth 3815.0. - Knox Daily
Ratios Reveal: Breaking Down Zai Lab Limited ADR (ZLAB)’s Financial Health - The Dwinnex
Insider Edmondson Frazor Titus III sells 1,924 of Zai Lab Limited ADR [ZLAB] Stock - Knox Daily
Recent Insider Activity Could Benefit Whitestone REIT (WSR) - Knox Daily
Petco Health and Wellness Co Inc [WOOF] Investment Appeal on the Rise - Knox Daily
Holdings of Zai Lab Limited ADR (ZLAB) are aligned with the stars - SETE News
Zai Lab Limited (ZLAB): Top ADR Stock According to Hedge Funds - MSN
Zai Lab Limited ADR (ZLAB) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Market Watch: Zai Lab Limited ADR (ZLAB)’s Noteworthy Gain, Closing at 19.55 - The Dwinnex
Zai Lab Limited (ZLAB): Top ADR Stock According to Hedge Funds - Insider Monkey
Zai Lab Limited (ZLAB): Top ADR Stock According to Hedge Funds - Yahoo Finance UK
Zai Lab Limited (ZLAB): Top ADR Stock According to Hedge Funds - Yahoo Finance
Are Zai Lab Limited ADR’shares a good deal? - US Post News
Analyzing Zai Lab Limited ADR (ZLAB) After Recent Trading Activity - Knox Daily
Zai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, at ESMO Congress 2024 - Business Wire
Top 10 ADR Stocks To Buy According to Hedge Funds - Insider Monkey
Contrasting Karyopharm Therapeutics (NASDAQ:KPTI) and Zai Lab (NASDAQ:ZLAB) - Defense World
Zai Lab Limited Adr Stock (ZLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):